A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders
(2003) In Australian Journal of Physiotherapy 49(2). p.107-116- Abstract
- We investigated if low level laser therapy (LLLT) of the joint capsule can reduce pain in chronic joint disorders. A literature search identified 88 randomised controlled trials, of which 20 trials included patients with chronic joint disorders. Six trials were excluded for not irradiating the joint capsule. Three trials used doses lower than a dose range nominated a priori for reducing inflammation in the joint capsule. These trials found no significant difference between active and placebo treatments. The remaining 11 trials including 565 patients were of acceptable methodological quality with an average PEDro score of 6.9 (range 5-9). In these trials, LLLT within the suggested dose range was administered to the knee, temporomandibular... (More)
- We investigated if low level laser therapy (LLLT) of the joint capsule can reduce pain in chronic joint disorders. A literature search identified 88 randomised controlled trials, of which 20 trials included patients with chronic joint disorders. Six trials were excluded for not irradiating the joint capsule. Three trials used doses lower than a dose range nominated a priori for reducing inflammation in the joint capsule. These trials found no significant difference between active and placebo treatments. The remaining 11 trials including 565 patients were of acceptable methodological quality with an average PEDro score of 6.9 (range 5-9). In these trials, LLLT within the suggested dose range was administered to the knee, temporomandibular or zygapophyseal joints. The results showed a mean weighted difference in change of pain on VAS of 29.8 mm (95% Cl, 18.9 to 40.7) in favour of the active LLLT groups. Global health status improved for more patients in the active LLLT groups ( relative risk of 0.52; 95% Cl 0.36 to 0.76). Low level laser therapy with the suggested dose range significantly reduces pain and improves health status in chronic joint disorders, but the heterogeneity in patient samples, treatment procedures and trial design calls for cautious interpretation of the results. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/309447
- author
- Bjordal, Jan M ; Couppé, Christian LU ; Chow, Roberta T ; Tuner, Jan and Ljunggren, Elisabeth Anne
- organization
- publishing date
- 2003
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- inflammation, meta-analysis, lasers, joint diseases
- in
- Australian Journal of Physiotherapy
- volume
- 49
- issue
- 2
- pages
- 107 - 116
- publisher
- Australian Physiotherapy Association
- external identifiers
-
- wos:000183424400004
- pmid:12775206
- scopus:0038717147
- ISSN
- 0004-9514
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Division of Physiotherapy (Closed 2012) (013042000)
- id
- 7c5f1115-7801-4450-ae12-a3c01e142ca0 (old id 309447)
- date added to LUP
- 2016-04-01 16:10:04
- date last changed
- 2022-04-07 03:27:15
@article{7c5f1115-7801-4450-ae12-a3c01e142ca0,
abstract = {{We investigated if low level laser therapy (LLLT) of the joint capsule can reduce pain in chronic joint disorders. A literature search identified 88 randomised controlled trials, of which 20 trials included patients with chronic joint disorders. Six trials were excluded for not irradiating the joint capsule. Three trials used doses lower than a dose range nominated a priori for reducing inflammation in the joint capsule. These trials found no significant difference between active and placebo treatments. The remaining 11 trials including 565 patients were of acceptable methodological quality with an average PEDro score of 6.9 (range 5-9). In these trials, LLLT within the suggested dose range was administered to the knee, temporomandibular or zygapophyseal joints. The results showed a mean weighted difference in change of pain on VAS of 29.8 mm (95% Cl, 18.9 to 40.7) in favour of the active LLLT groups. Global health status improved for more patients in the active LLLT groups ( relative risk of 0.52; 95% Cl 0.36 to 0.76). Low level laser therapy with the suggested dose range significantly reduces pain and improves health status in chronic joint disorders, but the heterogeneity in patient samples, treatment procedures and trial design calls for cautious interpretation of the results.}},
author = {{Bjordal, Jan M and Couppé, Christian and Chow, Roberta T and Tuner, Jan and Ljunggren, Elisabeth Anne}},
issn = {{0004-9514}},
keywords = {{inflammation; meta-analysis; lasers; joint diseases}},
language = {{eng}},
number = {{2}},
pages = {{107--116}},
publisher = {{Australian Physiotherapy Association}},
series = {{Australian Journal of Physiotherapy}},
title = {{A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders}},
volume = {{49}},
year = {{2003}},
}